Benzinga | Aug 4, 2021 07:18AM EDT

Editas Medicine Q2 EPS $(0.81) Beats $(0.83) Estimate, Sales $400.00K Miss $6.17M Estimate

Editas Medicine (NASDAQ:EDIT) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.83) by 2.41 percent. This is a 88.37 percent decrease over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $400.00 thousand which missed the analyst consensus estimate of $6.17 million by 93.52 percent. This is a 96.28 percent decrease over sales of $10.75 million the same period last year.